Cellectis SA (CLLS)
4.27
+0.18
(+4.40%)
USD |
NASDAQ |
Apr 16, 16:00
4.23
-0.04
(-0.94%)
After-Hours: 20:00
Cellectis Research and Development Expense (Quarterly) : 19.62M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| DBV Technologies SA | 30.04M |
| EDAP TMS SA | 2.107M |
| Sanofi | -- |
| Akari Therapeutics Plc | 1.084M |
| Biodexa Pharmaceuticals Plc | -- |